SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain Management Technology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of SciSparc Ltd. (SPRC) surged by more than 57% on Tuesday following the announcement that the company's patent application for a combination of opioids and N-Acylethanolamines for pain treatment has been accepted by IP Australia - the government agency responsible for administering intellectual property rights and patent legislation in Australia.
SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Tuesday after the company announced it was granted a European patent for its core technology.